http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1268171-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_492278f7fa4823de459db7b61382bd22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
filingDate 1983-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1986-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5008ca0b500939c8be3c5421b6805d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512678a2b5d650f23093d2432c478b76
publicationDate 1986-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1268171-A1
titleOfInvention Method of prophylaxis of acute adrenocortical insufficiency in surgical operations
abstract The invention relates to medicine and can be used to prevent acute adrenocortical insufficiency in operations. The purpose of the invention is to reduce complications. Before the operation, clinical and laboratory examination is performed. In the case of withdrawal of steroids treatment 2-5 months prior to surgical treatment, hydrocortisone is administered once at 1 mg / kg before surgery. When signs of acute adrenocortical insufficiency appear, this drug is administered (L even during surgery. If steroid therapy is discontinued less than 2 months before surgery, hydrocortisone is administered before, during and after surgery.) During steroid therapy, hydrocortisone is administered once before the operation, 1 mg / kg. During the operation, 1-2 daily doses of the drug are administered and after the operation a 1-day dose of the drug.
priorityDate 1983-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255

Total number of triples: 14.